Research graph
References from Disparities in staging prostate magnetic resonance imaging utilization for nonmetastatic prostate cancer patients undergoing definitive radiation therapy. Local targets link to admitted publications; unresolved targets remain external evidence.
Disparities at presentation, diagnosis, treatment, and survival in African American men, affected by prostate cancer
10.1002/pros.21314 · 2011 · External reference
Racial disparities in prostate cancer incidence, biochemical recurrence, and mortality
10.1155/2011/716178 · 2011 · External reference
African American men with very low-risk prostate cancer exhibit adverse oncologic outcomes after radical prostatectomy: Should active surveillance still be an option for them?
10.1200/jco.2012.47.0302 · 2013 · External reference
Pathological examination of radical prostatectomy specimens in men with very low risk disease at biopsy reveals distinct zonal distribution of cancer in black american men
10.1016/j.juro.2013.06.021 · 2014 · External reference
Clinical and demographic characteristics associated with prostate cancer progression in patients on active surveillance
10.1016/j.juro.2011.12.082 · 2012 · External reference
Endorectal coil magnetic resonance imaging identifies locally advanced prostate cancer in select patients with clinically localized disease
10.1016/s0090-4295(97)00630-4 · 1998 · External reference
Diffusion-weighted MRI of peripheral zone prostate cancer: Comparison of tumor apparent diffusion coefficient with Gleason score and percentage of tumor on core biopsy
10.2214/ajr.09.2651 · 2010 · External reference
Quantitative analysis of multiparametric prostate MR images: Differentiation between prostate cancer and normal tissue and correlation with Gleason score—a computer-aided diagnosis development study
10.1148/radiol.13121454 · 2013 · External reference
Prostate cancer: Multiparametric MR imaging for detection, localization, and staging
10.1148/radiol.11091822 · 2011 · External reference
Prediction of seminal vesicle invasion in prostate cancer: Incremental value of adding endorectal MR imaging to the Kattan nomogram
10.1148/radiol.2421051254 · 2007 · External reference
Guided e-MRI prostate biopsy can solve the discordance between Gleason score biopsy and radical prostatectomy pathology
10.1016/j.mri.2010.03.041 · 2010 · External reference
Pretreatment endorectal coil magnetic resonance imaging findings predict biochemical tumor control in prostate cancer patients treated with combination brachytherapy and external-beam radiotherapy
10.1016/j.ijrobp.2012.01.009 · 2012 · External reference
Prostate cancer: Role of pretreatment MR in predicting outcome after external-beam radiation therapy—initial experience
10.1148/radiol.2471061982 · 2008 · External reference
Pretreatment endorectal magnetic resonance imaging and magnetic resonance spectroscopic imaging features of prostate cancer as predictors of response to external beam radiotherapy
10.1016/j.ijrobp.2008.04.056 · 2009 · External reference
Predicting post-external beam radiation therapy PSA relapse of prostate cancer using pretreatment MRI
10.1016/j.ijrobp.2009.08.040 · 2010 · External reference
Prostate cancer: Prediction of biochemical failure after external-beam radiation therapy—Kattan nomogram and endorectal MR imaging estimation of tumor volume
10.1148/radiol.11110457 · 2011 · External reference
Breast MRI utilization in older patients with newly diagnosed breast cancer
10.1016/j.jss.2011.04.038 · 2011 · External reference
Disparities in colorectal cancer in African-Americans vs Whites: Before and after diagnosis
10.3748/wjg.15.3734 · 2009 · External reference
Multi-modality mediastinal staging for lung cancer among medicare beneficiaries
10.1097/jto.0b013e318197f4d9 · 2009 · External reference
Unresolved reference
External reference
Geocoding and monitoring of US socioeconomic inequalities in mortality and cancer incidence: Does the choice of area-based measure and geographic level matter? The Public Health Disparities Geocoding Project
10.1093/aje/kwf068 · 2002 · External reference
Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer
10.1001/jama.280.11.969 · 1998 · External reference
Unresolved reference
External reference
Unresolved reference
External reference
Re: prostate cancer imaging trends after a nationwide effort to discourage inappropriate prostate cancer imaging
2014 · External reference
Appropriateness of prostate cancer imaging among veterans in a delivery system without incentives for overutilization
10.1111/1475-6773.12395 · 2016 · External reference
Imaging and evaluation of patients with high-risk prostate cancer
10.1038/nrurol.2015.242 · 2015 · External reference
Preoperative nomograms incorporating magnetic resonance imaging and spectroscopy for prediction of insignificant prostate cancer
10.1111/j.1464-410x.2011.10612.x · 2012 · External reference
Guideline-discordant use of imaging during work-up of newly diagnosed prostate cancer
10.1200/jop.2014.001818 · 2015 · External reference
Disparities in lung cancer staging with positron emission tomography in the Cancer Care Outcomes Research and Surveillance (CanCORS) study
10.1097/jto.0b013e31821671b6 · 2011 · External reference
Race and survival of men treated for prostate cancer on radiation therapy oncology group phase III randomized trials
10.1016/s0022-5347(05)64078-5 · 2003 · External reference
Health consequences of uninsurance among adults in the United States: Recent evidence and implications
10.1111/j.1468-0009.2009.00564.x · 2009 · External reference
Cancer survival in Kentucky and health insurance coverage
10.1001/archinte.163.18.2135 · 2003 · External reference
Primary care physicians' perceptions of the effect of insurance status on clinical decision making
10.1370/afm.574 · 2006 · External reference
Physician response to patient insurance status in ambulatory care clinical decision-making. Implications for quality of care
10.1097/00005650-199608000-00006 · 1996 · External reference
Association of health insurance with outcomes in adults ages 18 to 64 years with melanoma in the United States
10.1016/j.jaad.2015.09.054 · 2016 · External reference
The Impact of insurance status on tumor characteristics and treatment selection in contemporary patients with prostate cancer
10.6004/jnccn.2015.0164 · 2015 · External reference
